Aprepitant: a novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma.
Publication
, Journal Article
Ladizinski, B; Bazakas, A; Olsen, EA
Published in: J Am Acad Dermatol
November 2012
Duke Scholars
Published In
J Am Acad Dermatol
DOI
EISSN
1097-6787
Publication Date
November 2012
Volume
67
Issue
5
Start / End Page
e198 / e199
Location
United States
Related Subject Headings
- Substance P
- Recombinant Proteins
- Pain Measurement
- Ondansetron
- Neurokinin-1 Receptor Antagonists
- Morpholines
- Lymphoma, T-Cell, Cutaneous
- Interferon-alpha
- Interferon alpha-2
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Ladizinski, B., Bazakas, A., & Olsen, E. A. (2012). Aprepitant: a novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma. J Am Acad Dermatol, 67(5), e198–e199. https://doi.org/10.1016/j.jaad.2012.02.008
Ladizinski, Barry, Andrea Bazakas, and Elise A. Olsen. “Aprepitant: a novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma.” J Am Acad Dermatol 67, no. 5 (November 2012): e198–99. https://doi.org/10.1016/j.jaad.2012.02.008.
Ladizinski B, Bazakas A, Olsen EA. Aprepitant: a novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma. J Am Acad Dermatol. 2012 Nov;67(5):e198–9.
Ladizinski, Barry, et al. “Aprepitant: a novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma.” J Am Acad Dermatol, vol. 67, no. 5, Nov. 2012, pp. e198–99. Pubmed, doi:10.1016/j.jaad.2012.02.008.
Ladizinski B, Bazakas A, Olsen EA. Aprepitant: a novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma. J Am Acad Dermatol. 2012 Nov;67(5):e198–e199.
Published In
J Am Acad Dermatol
DOI
EISSN
1097-6787
Publication Date
November 2012
Volume
67
Issue
5
Start / End Page
e198 / e199
Location
United States
Related Subject Headings
- Substance P
- Recombinant Proteins
- Pain Measurement
- Ondansetron
- Neurokinin-1 Receptor Antagonists
- Morpholines
- Lymphoma, T-Cell, Cutaneous
- Interferon-alpha
- Interferon alpha-2
- Humans